Riverbend Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
5,704
+268
+5% +$62.5K 0.73% 41
2026
Q1
$1.33M Buy
5,436
+182
+3% +$42.4K 0.76% 34
2025
Q4
$1.09M Buy
5,254
+424
+9% +$83.8K 0.68% 42
2025
Q3
$896K Buy
4,830
+24
+0.5% +$4.11K 0.63% 41
2025
Q2
$734K Sell
4,806
-22
-0.5% -$3.38K 0.56% 49
2025
Q1
$801K Buy
4,828
+215
+5% +$33.6K 0.72% 43
2024
Q4
$669K Buy
+4,613
New +$715K 0.6% 45

Other funds holding JNJ

Riverbend Wealth Management's JNJ Position: Q2 2026 in Review

Riverbend Wealth Management increased its Johnson & Johnson (JNJ) stake by 4.9% in Q2 2026, buying an estimated $62.5K and bringing the position to 5,704 shares worth $1.45M. The position accounts for 0.73% of the portfolio, ranked #41.

Riverbend Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,401 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Riverbend Wealth Management held 5,704 shares of Johnson & Johnson worth $1.45M as of Q2 2026.
  • Riverbend Wealth Management bought 268 Johnson & Johnson shares in Q2 2026, an estimated $62.5K.
  • Johnson & Johnson made up 0.73% of Riverbend Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Riverbend Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,401 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Riverbend Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.